B3BN Stock Overview
CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
CVR Medical Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.007 |
52 Week High | CA$0.032 |
52 Week Low | CA$0.007 |
Beta | -0.19 |
1 Month Change | 0% |
3 Month Change | -26.32% |
1 Year Change | -39.13% |
3 Year Change | n/a |
5 Year Change | -97.26% |
Change since IPO | -97.20% |
Recent News & Updates
Recent updates
Shareholder Returns
B3BN | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | 0% | -5.0% | -2.0% |
1Y | -39.1% | -13.6% | -0.3% |
Return vs Industry: B3BN underperformed the German Medical Equipment industry which returned -2.5% over the past year.
Return vs Market: B3BN underperformed the German Market which returned 5.9% over the past year.
Price Volatility
B3BN volatility | |
---|---|
B3BN Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 4.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: B3BN's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine B3BN's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1980 | n/a | Darren Day | www.cvrmed.com |
CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers.
CVR Medical Corp. Fundamentals Summary
B3BN fundamental statistics | |
---|---|
Market cap | €1.51m |
Earnings (TTM) | -€1.59m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.9x
P/E RatioIs B3BN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
B3BN income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$1.62m |
Earnings | -US$1.62m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.012 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | -12.0% |
How did B3BN perform over the long term?
See historical performance and comparison